Product Name: Capecitabine
CAS NO: 154361-50-9
MF: C15H22FN3O6
MW: 359.35
Appearance: White Powder
Description: Capecitabine is an antimetabolite fluoropyrimidine deoxynucleoside carbamate that can be converted into 5-FU in vivo, which inhibits cell division and interferes with RNA and protein synthesis.
1.Indicated for the further treatment of advanced primary or metastatic breast cancer that is refractory to paclitaxel and chemotherapy regimens including anthracyclines.
2.For the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance